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1116-39 QRS Duration Does Not Predict Occurrence of 
Ventricular Tachyarrhythmias in Primary Prevention 
Patients With Implantable Cardioverter-Defibrillators
Alfred E. Buxton, Michael O. Sweeney, Elaine Hogan Miller, Mary Otterness, Mark 
Wathen, Alice Stark, Brown Medical School, Providence, RI, Brigham and Women's 
Hospital, Boston, MA
Background: QRS duration (QRSd), measured on a standard ECG, correlates with total
mortality risk in coronary artery disease (CAD) patients (pts) at high risk for sudden
death. However, the relationship between QRSd and risk of ventricular tachyarrhythmias
(VT/VF) is unclear.
Methods: PainFREE RX II (N=636) was a randomized trial comparing efficacy of anti-
tachycardia pacing vs. shock therapy for fast VT (cycle length (CL) <=320msec) in pts
receiving implanted cardioverter-defibrillators (ICD). Detection criteria were programmed
uniformly, and available stored electrograms of VT/VF episodes were analyzed by an
expert panel to verify ventricular origin of tachycardias. We correlated the QRSd on the
12 Lead ECG at study entry with occurrence of VT/VF during the trial.
Results: Of 168 CAD pts enrolled for primary prevention, 91 had QRSd <=120 msec, 77
had QRSd >120 msec. Over a mean follow-up of 11±3 months, VT/VF episodes occurred
in 19/91 (21%) pts with QRSd <=120 msec vs. 17/77 (22%) pts with QRSd >120 msec.
The odds of episodes in pts with QRS >120msec is 1.07 times that of patients with QRSd
<=120 (95% C.I. =0.51-2.25; p=0.85). We evaluated the sensitivity and specificity of
QRSd in intervals of 0 msec ranging from 70 to 200. Sensitivity is the proportion of pts
experiencing VT/VF episodes above each QRSd, reported in msec. Specificity is the pro-
portion of true negatives below each reported QRSd. The optimal combination of sensi-
tivity (75%)and specificity (42%) was obtained at QRSd 110 msec. Among patients who
had VT/VF episodes, patients with QRSd >120 msec (median 2/pt) did not have signifi-
cantly more episodes than those with QRSd <=120 msec (median 1/pt) (p=0.34).
Summary: 1. There is no evidence of a difference in the proportion of patients experienc-
ing VT/VF having QRSd >120 vs <=120 msec. 2. We found no QRSd that resulted in
acceptable sensitivity and specificity in this study population.
Conclusions: 1. QRSd is not useful clinically to predict primary prevention pts who will
benefit from ICDs. 2. The utility of QRSd to predict VT/VF events in patients with CAD
requires further prospective evaluation.
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1116-40 Regional Distribution of Depolarization Alternans 
Preceding Ventricular Fibrillation Onset in a Canine 
Ischemic Model
David Gordon, Taresh Taneja, Daniel Koolish, David Johnson, Joseph S. Ulphani, Jeffrey 
Goldberger, Alan Kadish, Northwestern University Medical School, Chicago, IL, Hartley 
Data Inc., Glenview, IL
Repolarization alternans is associated with spontaneous arrhythmias. We devised an
algorithm to quantify the degree of alternans in a 4 second window and tested it on epi-
cardial electrograms from normal and ischemic dogs during sinus rhythm. Methods: Uni-
polar electrograms were recorded from a 112 electrode plaque placed on the left
ventricle from 21 dogs before and 3-5 minutes after ligation of the left anterior descend-
ing artery (LAD). Sites were graded into R1(no ischemia),R2 and R3 (severe ischemia).
The algorithm was used to detect alternans in the QRS and ST-T segment by fitting a
saw-tooth against sequential peak-to-peak QRS and T wave amplitudes. The amplitude
of the best fit saw-tooth was the alternans amplitude (AA). The alternans index (AI) was
computed as the ratio of the AA divided by an error term. Results: The baseline QRS and
ST/T AI was 1.06 ±1.2 and 1.48±2.06 and it increased to 2.99±6.31 and 5.73 ±11.0
respectively (P<0.0001 for each) after LAD occlusion. Six dogs developed spontaneous
VF during ischemia and had a higher mean QRS and ST/T AI at sites with maximal
ischemia before VF onset as opposed to dogs with no spontaneous VF who had the
highest AI at sites with no ischemia (Table).Conclusions: This algorithm showed that
depolarization and repolarization alternans increase during ischemia. In dogs with VF
depolarization alternans preceding VF originates in the ischemic zone whereas dogs
without VF have more alternans in regions without ischemia. This may simplify clinical
alternans measurements. 
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1116-40A Spectrum and Frequency of Channelopathies in Near-
Drownings
Grace R. Choi, David J. Tester, Melissa L. Will, Laura J. Kopplin, Carla M. Bell, Michael J. 
Ackerman, Mayo Clinic, Rochester, MN
Background: Among families with clinical evidence of long QT syndrome (LQTS), a per-
sonal/family history of a swimming-triggered cardiac event is virtually synonymous for
type 1 LQTS (LQT1). However, the spectrum and frequency of cardiac channel mutations
is unknown when the principal presentation involves a near-drowning or drowning.
Methods: Nearly 500 unrelated patients have been referred to Mayo Clinic’s Sudden
Death Genomics Laboratory for LQTS genetic testing since 1997. The results of the car-
diac channel gene screen that included KCNQ1 (LQT1), KCNH2 (LQT2), SCN5A
(LQT3), KCNE1 (LQT5), KCNE2 (LQT6), KCNJ2 (Andersen syndrome 1), and RYR2
(catecholaminergic polymorphic ventricular tachycardia, CPVT1) were reviewed retro-
spectively in those patients with a personal and/or family history of an unexplained near-
drowning or drowning.
Results: Approximately 7% (N=35) of the entire cohort was referred on the basis of
either a personal (N=23) and/or family history (N=14) of near-drowning or drowning.
Among the LQTS-causing genes, LQT1-causing mutations were identified in 21 (60%)
and LQT2-causing mutations in 2 (5.7%). No mutations were identified in SCN5A,
KCNE1, KCNE2, or KCNJ2. However, 8 patients (22.8%) had putative CPVT1-causing
mutations involving the cardiac ryanodine receptor encoded by RYR2.
Conclusion: In contrast to previous studies that involved patients with a clinical diagno-
sis of LQTS, there is genetic heterogeneity associated with swimming-triggered cardiac
events when a channelopathy is suspected chiefly because of a near-drowning or drown-
ing. In this setting, LQT1 accounts for 60% of the entire cohort and comprised the vast
majority of LQTS-causing genotypes (91%). To our surprise, nearly 1 out of 4 cases
involving a near-drowning or drowning had a putative CPVT1-causing RYR2 mutation.
CPVT and strategic genotyping of RYR2 should be considered when LQT1 is excluded in
the pathogenesis of an unexplained near-drowning.
Regional variability in QRS and ST/T AI in dogs with and without spontaneous 
VF
No VF Spontaneous VF
R1 R2 R3 R1 R2 R3
QRS AI 3.41±9.19* 2.26±4.74 2.02±3.01 1.68±1.56 1.93±2.91 5.86±7.57†
ST/T AI 4.97±9.51* 3.68±7.61 2.88±6.01 4.27±5.75 7.23±8.26§ 13.73±18.78‡
* p < 0.005 vs R2 and R3, † p < 0.05 vs. R1 and R2, ‡ p < 0.001 vs R1, § p < 0.0.001 
vs R1
